BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer
Clinical trial NCT04777708 · TERMINATED
Trial details
- NCT number
- NCT04777708
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-13
- Primary completion
- 2023-03-13
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.